LITHOBID
Health Topics Pharma News Home
Pharma News Home
FDA Approval Activities for this Drug Lithobid Slow Release Tablets, 300 mg, Solvay NDA 18-027/S-040, S-046, S-049
Lithobid Slow Release Tablets, 300 mg, Solvay NDA 18-027/S-040, S-046, S-049
For the latest approval information, please locate this drug using this index.